local drug delivery

Original Contribution

Nitroglycerin-Derived Pd/Pa for the Assessment of Intermediate Coronary Lesions

08/15/2017

Zeev Israeli , MD;

Rodrigo Bagur , MD, PhD;

Dorian Murariu , MSc;

Sabrina Wall , BSc;

Mistre Alemayehu , MSc;

Yasir Parviz , MBBS, MRCP;

Pantelis Diamantouros , MD;

Shahar Lavi , MD, PhD;

This study assesses the predictive value of Pd/Pa after nitroglycerin administration as compared with standard fractional flow reserve (FFR).

This study assesses the predictive value of Pd/Pa after nitroglycerin administration as compared with standard fractional flow reserve (FFR).

This study assesses the...

08/15/2017

Journal of Invasive Cardiology

Clinical Review

Contrast Induced Nephropathy: How to Avoid a Life of CIN

03/05/2014

Barry S. Weinstock , MD, FACC;

The author discusses established and evolving strategies to decrease the risk of contrast nephropathy.

The author discusses established and evolving strategies to decrease the risk of contrast nephropathy.

The author discusses established...

03/05/2014

Vascular Disease Management

Case Report

ClearWay RX-Directed Combination Thrombolytic and Glycoprotein IIb/IIIa Therapy With Embolic Protection Device in an Acute Upper Extremity Occlusion

07/02/2013

Rajesh M. Dave , MD, FACC, FSCAI;

Richard J. Markiewicz , MD;

Shawn Colby , RN;

A 75-year-old patient who presented with acute left upper limb ischemia with rest pain, pallor, and partial paralysis was successfully treated with with a combined approach consisting of an embolic protection device, intralesion delivery of...

A 75-year-old patient who presented with acute left upper limb ischemia with rest pain, pallor, and partial paralysis was successfully treated with with a combined approach consisting of an embolic protection device, intralesion delivery of...

A 75-year-old patient who...

07/02/2013

Vascular Disease Management

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

NP Institute

March 27 ⁠–⁠ March 30

March 31 ⁠–⁠ April 2

April 21 ⁠–⁠ April 24

April 30 ⁠–⁠ May 4

April 30 ⁠–⁠ May 5

WoundCon

May 1 ⁠–⁠ May 3

May 19 ⁠–⁠ May 21

See Full Calendar